Enzyme‐Activatable Probe for Tumor Bimodal Imaging, Intraoperative Navigation, and Urinalysis
Advanced Healthcare Materials · 2026
DOI: 10.1002/adhm.71862 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Healthcare Materials, 2026. Verfasst von Meilin Xu und 4 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Chemical Resource Engineering, Beijing Key Laboratory of Intelligent Nanomedicine and Tracing, College of Chemistry, Beijing …. Hauptthemen laut MEDLINE: Urinalysis, Neoplasms, Multimodal Imaging. Die Arbeit nennt 46 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Fundamental Research Funds for the Central Universities.
Abstract (Originalsprache)
We develope an enzyme‐activatable platform ( NO 2 ‐RGD‐Gd ) for the integrated urinary biomarker detection, highcontrast fluorescence‐magnetic resonance (MR) dualmodal imaging, and real‐time image‐guided surgical navigation within a single molecule. The advantages, including the favorable tumor‐targeting affinity (RGD peptide), high renal clearance efficiency, and tumor‐specific fluorescence activation, are achieved by rationally engineering the molecular architecture. Benefiting from these characteristics, the NO 2 ‐RGD‐Gd effectively bridges the boundary between diagnosis and therapy, achieving outstanding combinatorial performance in in vivo applications. It allows early and precise diagnosis through urinary biomarkers, provides anatomical‐pathological and molecular imaging information of tumor lesions via fluorescence‐MR dual‐modal imaging, and delineates tumor boundaries for accurate surgical navigation relying on tumor‐targeted activatable fluorescence imaging signals. Furthermore, all these processes can be realized simply via intravenous injection, offering a more efficient and feasible strategy for integrated diagnostic and therapeutic applications.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Chemical Resource Engineering, Beijing Key Laboratory of Intelligent Nanomedicine and Tracing, College of Chemistry, Beijing University of Chemical Technology, Beijing, P. R. China.
ORCID-Profile: Yu Wang, Xiaole Zhou, Leyu Wang
Förderung
- National Natural Science Foundation of China
- Fundamental Research Funds for the Central Universities
Zitieren
APA
Xu, M., Dong, Y., Wang, Y., Zhou, X., & Wang, L. (2026). Enzyme‐Activatable Probe for Tumor Bimodal Imaging, Intraoperative Navigation, and Urinalysis. Advanced Healthcare Materials. https://doi.org/10.1002/adhm.71862
Vancouver
Xu M, Dong Y, Wang Y, Zhou X, Wang L. Enzyme‐Activatable Probe for Tumor Bimodal Imaging, Intraoperative Navigation, and Urinalysis. Advanced Healthcare Materials. 2026. doi:10.1002/adhm.71862
BibTeX
@article{Xu2026,
author = {Xu, Meilin and Dong, Yao and Wang, Yu and Zhou, Xiaole and Wang, Leyu},
title = {Enzyme‐Activatable Probe for Tumor Bimodal Imaging, Intraoperative Navigation, and Urinalysis},
journal = {Advanced Healthcare Materials},
year = {2026},
doi = {10.1002/adhm.71862}
}
EUVIMED